Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Osteosarcoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Specimen Handling 271Magnetic Resonance Spectroscopy 228pembrolizumab 219Carboplatin 180Cisplatin 146Biopsy 143Cyclophosphamide 137Paclitaxel 128Nivolumab 117Gemcitabine 105Bevacizumab 104Radiotherapy 86Dexamethasone 83Pemetrexed 79fludarabine 73Fluorouracil 73Docetaxel 73Doxorubicin 72atezolizumab 71Radiation 71Leucovorin 68Rituximab 65Oxaliplatin 64venetoclax 60Prednisone 59durvalumab 58Cetuximab 56Vincristine 55Etoposide 54Lenalidomide 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Pafolacianine × 30 days × Clear all
NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting
10 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT07039526 2026-06-05

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

University of Texas Southwestern Medical Center

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Gastrointestinal Neoplasms

NCT06434909 2026-06-01

CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer

Indiana University

Phase 2 Completed
9 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡